Focused Ultrasound for PTSD in Veterans
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06820138
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Brainsonix Ultrasound Device — DEVICEThis device delivers low intensity focused ultrasound and delivers either active or sham sonication depending upon the transducer pad used.
Study Details
The goal of this study is to develop a new, non-invasive brain stimulation modality called low intensity focused ultrasound (FUS) as a psychiatric rehabilitation treatment for posttraumatic stress disorder (PTSD). FUS delivers energy comparable to that involved in diagnostic ultrasound but in a millimeter-sized envelope. Unlike currently available methods, the maximal FUS energy is delivered at a distance from a transducer on the scalp. Therefore, its promise is that it can deliver focal and reversible modulation to deeper brain regions involved in PTSD. The investigator team has previously conducted first-in-human research in FUS, and this study builds upon that work to conduct a phase II, dose-finding study. This study will pursue two Aims; the first is whether FUS to the amygdala can improve symptoms, and the second will evaluate whether FUS improves function by reduced disability, over a 1-month period. Short and longer-term effects of FUS will be measured and all FUS parameters are within FDA-defined safety thresholds for diagnostic ultrasound.
Key Dates
- Start date
- Aug 3, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2029
- Completion
- Mar 29, 2030
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Verum low intensity focused ultrasoundVerum (active) low intensity focused ultrasound, applied up to three times per week.
- Sham Comparator: Sham low intensity focused ultrasoundSham (inactive) low intensity focused ultrasound, applied up to three times per week.
Primary Outcome Measure
PTSD Checklist for DSM5 [ Time Frame: Up to 3 months ]
Central Contacts
- Noah S Philip, MD(401) 273-7100
- Alison Gorbatov(401) 271-7100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Providence VA Medical Center, Providence, RI | Providence | Rhode Island | 02908-4734 | Amy Mochel Noah S. Philip, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Providence, RI
Related Studies
- Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing TherapyEnrolling By Invitation · Milissa Kaufman · Belmont, Massachusetts
- Biomolecular Characteristics of Reminder-Focused Positive-PsychiatryRecruiting · University of California, Los Angeles · Los Angeles, California
- Repurposing Low-Dose Clonidine for PTSD in VeteransPHASE3 · Recruiting · Wake Forest University Health Sciences · Wauwatosa, Wisconsin
- Piloting Virtual Reality Environments to Treat PTSD in Healthcare WorkersEARLY_PHASE1 · Recruiting · Weill Medical College of Cornell University · New York, New York